News

ASML Stock Jumps 4.1% as TSMC Revenue Reignites Tool Demand

JBL's cheaper valuation, broader AI hardware exposure and stronger 2026 growth estimates give it an edge over GLW despite its bigger rally.

KDP vs. MNST: Which Stock Is the Better Value Option?

Archer Aviation is surging for a second straight day while rivals Joby and EHang sit completely frozen, and the reason traces back to a Boeing deal detail that changes how Archer plans to fund its entire future.

Hims & Hers Health (NYSE:HIMS) delivered mixed second-quarter results, with revenue beating Wall Street expectations while its quarterly loss came in wider than analysts had forecast as the company incurred restructuring charges tied to its shift toward branded GLP-1 weight-loss...

RGTI's Q2 revenues surge 185% as QPU sales and technology gains boost momentum, but heavy losses and uneven demand keep caution in focus.

The broad index is now far more expensive than it was before its most recent crash in 2022.

RadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.

Polymarket now prices real odds of a September rate hike, and that puts millions of investors holding the most popular dividend ETF in a position their fund was never designed to handle. Fidelity quietly built something for exactly this moment.

Eli Lilly just posted its fourth straight earnings beat and raised guidance again, but the real question is whether a next-generation obesity drug still sitting below Wall Street's radar could push the stock well past current targets.

Sea (SE) reported stronger-than-expected second-quarter revenue on Tuesday as the Singapore-based co

This under-the-radar insurance stock boasts a Superscore of 74 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

ALH's resilient growth and stronger balance sheet support its case, but margin pressure and a moderate valuation demand execution.

ALH's 10.5% three-month gain has fundamental support, but margin pressure and Europe risks could test whether the rally can keep building.

Aptiv's low valuation and margin gains stand against weaker estimates, reduced guidance and pressured cash flow, keeping the near-term setup uncertain.

Quantum Computing's Q2 loss matches estimates as revenues surge on photonics sales, but higher costs and gross loss pressure profitability.

Quantum ETFs are gaining momentum as U.S. funding and breakthroughs accelerate the sector, offering investors diversified exposure to its growth.

OBDC's Q2 earnings beat estimates as lower interest expenses help offset weaker interest income and declining net investment income.

PWR's record backlog, strong execution and raised 2026 outlook support long-term growth despite near-term macro and project risks.

Disney's new CEO has a big chance to make waves this week, and shareholders are ready to surf.

ORCL's AI infrastructure bet is driving rapid cloud growth and huge contracts, but soaring spending and debt raise balance-sheet risks.

RTX's recent rally is supported by defense contract wins, technology milestones and rising 2026 estimates, despite its premium industry valuation.

StoneX posted sharp Q3 earnings growth as R.J. O'Brien synergies reached $38M, with further gains expected despite retail weakness and rising costs.

DK posts a major Q2 earnings gain as stronger refining margins and record logistics results drive EBITDA higher.

CEO Eric Brock said the award validates Ondas' position as a “prime contractor” for next-generation defense programs.

Could GS's M&A leadership, record investment-banking backlog and AI push fuel further growth? Let us find out.

Micron shares have shed 17% in weeks while bears pile on with cyclical fears and profit-taking warnings, yet the company just posted the strongest fundamentals in its history with more records on the way.

StoneX pairs strong earnings growth and expanding scale with a premium valuation, leaving investors to weigh momentum against margin and credit risks.

The average of price targets set by Wall Street analysts indicates a potential upside of 106.1% in Evolus (EOLS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at a 32.6% upside potential for DigitalOcean (DOCN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.